Prognostic Significance of Genome-Wide DNA Methylation Profiles in Non–1p/19q-Deleted Anaplastic Glioma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Prognostic Significance of Genome-Wide DNA Methylation Profiles Within the Randomised, Phase 3, EORTC CATNON Trial on Non-1p/19q Deleted Anaplastic Glioma
Neuro-oncology 2021 Apr 29;[EPub Ahead of Print], CMS Tesileanu, MJ van den Bent, M Sanson, W Wick, AA Brandes, PM Clement, SC Erridge, MA Vogelbaum, AK Nowak, JF Baurain, WP Mason, H Wheeler, OL Chinot, S Gill, M Griffin, L Rogers, W Taal, R Rudà, M Weller, C McBain, ME van Linde, TS Sabedot, Y Hoogstrate, A von Deimling, I de Heer, WFJ van IJcken, RWW Brouwer, K Aldape, RB Jenkins, HJ Dubbink, JM Kros, P Wesseling, KJ Cheung, V Golfinopoulos, BG Baumert, T Gorlia, H Noushmehr, PJ FrenchFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.